Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

How a Natural Sense of Curiosity Has Driven to the Top with Neustar's Sales Leader Dorean Kass

How a Natural Sense of Curiosity Has Driven to the Top with Neustar's Sales Leader Dorean Kass

FromSales Game Changers | Tips from Successful Sales Leaders


How a Natural Sense of Curiosity Has Driven to the Top with Neustar's Sales Leader Dorean Kass

FromSales Game Changers | Tips from Successful Sales Leaders

ratings:
Length:
30 minutes
Released:
Jan 17, 2018
Format:
Podcast episode

Description

This is episode 034. Read the complete transcript to this podcast on The Sales Game Changers site. Dorean Kass is the VP of Sales for Analytics Solutions at Neustar, Inc, a trusted neutral provider of real-time information services based in McLean, Virginia. Dorean leads strategic sales, channel initiatives, account management and inside sales focused on marketing analytics and fraud risk and compliance solutions. Dorean and his team help top brands across multiple verticals improve risk mitigation strategies, operational efficiency, acquisition and consumer insight in real-time across any channel. Prior to Neustar, Dorean spent six years in the tech consulting and software space. He received an undergraduate degree in Political Science and Economics from Stanford University. Find Dorean on LinkedIN!
Released:
Jan 17, 2018
Format:
Podcast episode

Titles in the series (100)

Institute for Excellence in Sales co-founder Fred Diamond interviews top business-to-business sales leaders from companies such as Cisco, AT&T, Oracle, Microsoft, Salesforce, Hilton and others about their sales journey, career highlights, mentors, and lessons learned while asking them to offer tips to help emerging sales professionals and leaders to grow their careers. It's an interview-style podcast that has become even more popular as sales professionals look for solutions during the COVID-19 pandemic.